Home
Knowledge Hub

Knowledge Hub

A new statistical method to assess in vitro bioequivalence of nasal products

05/06/2021

A new statistical method to assess in vitro bioequivalence of nasal products Bioequivalence testing is an essential step during the development of ...

Press Article

Integrated turnkey solutions: key to successful nasal combination product development

05/06/2021

Nemera is developing and manufacturing complex nasal drug delivery solutions.

International Women’s Day 2021 – #choosetochallenge

05/06/2021

Celebrating our leaders, not with a rose, but with a voice. An equal world is an empowered world. At Nemera, each individual is unique with a unique story ...

Marc Hämel’s insights in MassMEDIC’s annual DDD report

05/06/2021

Nemera - an integrated CDMO and Own-IP player In this report, Alira Health in partnership with MassMEDIC analyzes the rapidly evolving DDD ...

Nemera and Noble’s strong collaboration featured in The Pharmaceutical Post’s special edition on Injectables

05/06/2021

Nemera and Noble collaboration for training on Safe'n'Sound® 2.25 ml As one of the world’s leading providers of design, development and manufacturing of drug delivery devices, we announced the conclusion...

Nemera expands diabetes device portfolio and prepares for the future

05/06/2021

Nemera is a leading designer and leading provider of injectable delivery systems, offering different pen and auto-injector platforms for the treatment of diabetes.